The more addiction and recovery stories healthcare leaders hear, the harder it becomes to reduce substance use disorder to a stereotype. That is exactly why stories like Harry Cunnane’s matter.
In a recent Rxpert Solutions podcast conversation, Harry Cunnane of Caron Treatment Centers shared a deeply personal account of how his substance use disorder developed, how shame delayed treatment, and how recovery became possible when he finally understood addiction as a healthcare issue rather than a moral failure. His story is especially relevant for professionals working in drug diversion mitigation, because it reminds us that behind every suspicious pattern, every policy breach, and every monitoring alert is still a human being.
That perspective does not reduce accountability. It improves it.
According to SAMHSA’s July 28, 2025 release on the 2024 National Survey on Drug Use and Health, 23.5 million U.S. adults considered themselves to be in recovery or to have recovered from a drug or alcohol problem. That scale alone should challenge the idea that substance use disorder is rare, obvious, or confined to one “type” of person.
Start with a clear diversion risk picture. If your organization hasn’t conducted a recent diversion risk review, now is the time.
→ Request a Free 30-Minute Drug Diversion Risk Assessment
Harry Cunnane’s Story Shows How Substance Use Disorder Can Develop Slowly
One of the most important parts of Harry’s story is how ordinary it began.
He described growing up in a loving home, not as someone who fit a dramatic stereotype of addiction, but as someone who slowly crossed lines that initially felt normal or manageable. Alcohol became marijuana. Marijuana became cocaine. Eventually, cocaine gave way to illegally sourced prescription opioids. Like many people with substance use disorder, he did not begin with an intention to lose control. The progression was gradual, and the consequences accumulated before he fully understood what was happening.
That pattern matters in healthcare.
Healthcare leaders often assume a struggling employee will be easy to identify. But real life is usually messier. A person may still be functioning at work, caring for family, and maintaining appearances while their health, judgment, or behavior quietly deteriorates. Harry’s story is a reminder that substance use disorder often hides behind performance, denial, and fear rather than obvious collapse.
This is one reason proactive organizations invest in identifying the signs of addiction and building stronger monitoring systems before a crisis forces action.
Why Stigma Delays Treatment and Increases Risk
A central theme in the podcast was shame.
Harry explained that he did not initially see himself as a sick person needing treatment. He saw himself as a bad person making bad choices. That belief kept him from asking for help even when the damage was already severe.
That experience aligns with what federal health agencies continue to emphasize. NIDA states that substance use disorders are chronic, treatable medical conditions, yet stigma and discrimination still affect how people are viewed and treated. CDC also notes that stigma can stop people from seeking help, disclosing concerns, or accessing effective care.
In healthcare settings, stigma can be especially damaging because it changes how colleagues, managers, and even investigators interpret behavior. When a team defaults to moral judgment, it can delay reporting, discourage disclosure, and make intervention more reactive than clinical. When a team uses person-first language and understands substance use disorder as healthcare, it becomes easier to act earlier and more effectively. NIDA specifically recommends language choices that reduce shame and bias, such as “person with a substance use disorder” instead of labels like “addict.”
What Healthcare Leaders Can Learn from Recovery Stories
Recovery stories are not just inspirational. They are operationally useful.
Not everyone who is struggling will “look impaired”
Harry’s story reinforces that substance use disorder can remain hidden for a long time. In healthcare, that means leaders cannot rely only on visible impairment or dramatic behavioral events. A stronger model combines observation, reporting pathways, transaction monitoring, and clear escalation procedures.
High performers may still be high risk
The podcast also touched on a critical point for working professionals: success does not create immunity. Someone may be highly educated, well compensated, respected, and still living with a severe substance use disorder. In healthcare, this is especially important because access, opportunity, and stress can coexist with high professional competence.
Early intervention matters
SAMHSA describes SBIRT as a public-health approach for early intervention and treatment referral for people with substance use disorders or those at risk of developing them. In practical terms, earlier identification creates more treatment options and may reduce harm to both the individual and patients.
Support and accountability work best together
The most effective response is rarely “ignore it” or “punish it.” Recovery stories show the value of both compassion and structure. That is a lesson diversion programs should take seriously.
Why Long-Term Recovery Support Matters
Another strong takeaway from the interview is that recovery is not typically solved in one short episode of care.
Harry described the importance of quality treatment, structured support, and accountability over time. That perspective is consistent with SAMHSA’s current recovery guidance, which emphasizes that people can recover and manage their conditions successfully, especially when support extends beyond acute treatment.
This point is particularly relevant for healthcare professionals. Evidence from physician health program research has shown strong long-term outcomes when treatment is paired with extended monitoring, accountability, and recovery support. A five-year cohort study published by BMJ reported that most physicians who were followed in physician health programs had no known alcohol or drug misuse at follow-up and most were practicing medicine. Research on nurse monitoring programs likewise found that longer program participation was associated with successful completion.
For hospital leaders, the implication is clear: one-time intervention is not enough. Sustainable recovery often depends on a longer care model that includes treatment, monitoring, peer support, testing, return-to-work structure, and family involvement.
Every healthcare organization needs a clear diversion mitigation strategy. Independent evaluations can identify monitoring gaps before they become compliance issues.
→ Speak With a Diversion Mitigation Specialist
The Family Side of Substance Use Disorder Is Often Overlooked
Harry also discussed the memoir he co-authored with his mother, Congresswoman Madeleine Dean: Under Our Roof: A Son’s Battle for Recovery, a Mother’s Battle for Her Son. The book highlights something healthcare organizations sometimes miss: addiction is not experienced by one person alone. It reshapes relationships, trust, finances, communication, and daily life across the entire family system.
That matters in workplace settings too.
Substance use disorder impacts not only the employee but also coworkers, managers, investigators, and leadership teams trying to determine what is happening and how to respond. In the same way families may struggle with denial, fear, and trust, organizations often hesitate because they do not want to believe a respected colleague could be involved.
This is why response frameworks should account for the emotional reality of these situations, not just the compliance checklist.
How This Applies to Drug Diversion Mitigation in Healthcare
Humanizing addiction does not mean lowering standards. It means designing better systems.
A strong drug diversion mitigation program should still protect patients, investigate discrepancies, preserve evidence, and meet regulatory expectations. But it should also recognize that substance use disorder is a health condition that benefits from timely identification and referral.
That means organizations should:
- detect unusual patterns early
- train leaders to respond consistently
- use person-first, non-stigmatizing language
- distinguish fact-finding from shaming
- build referral pathways for evaluation and treatment
- support compliant return-to-work decisions when appropriate
This is where a mature mitigation program becomes more effective than a purely punitive one. It protects patient safety while improving the odds that an employee gets help before the consequences become catastrophic.
What a Better Diversion Mitigation Culture Looks Like
Harry’s story points toward a better model for healthcare organizations.
It is a culture where leaders understand that addiction can affect good people from good families. It is a culture where stigma does not delay action. It is a culture where a concerning pattern triggers a structured response rather than gossip, fear, or avoidance.
Practically, that culture includes:
- routine risk assessment
- clear reporting channels
- trained managers and investigators
- cross-functional coordination between pharmacy, nursing, compliance, HR, and legal
- documented procedures for intervention and follow-up
- outside expertise when internal teams need support
Most importantly, it includes the discipline to treat substance use disorder as healthcare while still addressing patient safety risks with urgency.
Empathy Is Not a Soft Skill in Diversion Mitigation
For healthcare leaders, recovery stories are more than compelling narratives. They are a reminder that the people who need help most may be the ones least likely to ask for it.
Harry Cunnane’s story illustrates how shame can delay treatment, how family systems absorb the damage, and how recovery becomes possible when addiction is treated as a medical condition with accountability, support, and time. For organizations responsible for diversion mitigation, that mindset is not optional. It is part of building a safer, smarter, and more humane response.
Many hospitals don’t discover diversion risks until after an incident. A structured evaluation of medication workflows can reveal vulnerabilities early.
→ Explore On-Site Drug Diversion Risk Assessment Service
